PDF herunterladen
Thromb Haemost 2006; 96(02): 111-112
DOI: 10.1160/TH06-07-0380
Editorial Focus
Schattauer GmbH

Arterial disease and venous thromboembolism: A modern paradigm?

Patrick K. Y. Goon
1   Haemostasis, Thrombosis and Vascular Biology Unit, University, Department of Medicine, City Hospital, Birmingham, UK
,
Gregory Y. H. Lip
1   Haemostasis, Thrombosis and Vascular Biology Unit, University, Department of Medicine, City Hospital, Birmingham, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 11. Juli 2006

Accepted 12. Juli 2006

Publikationsdatum:
28. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Choudhury A, Lip GYH. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 2003/2004; 33: 282-9.
    PubMedGoogle Scholar
  • 2 Lip GYH, Varma C. Anticoagulation plus aspirin following acute myocardial infarction: Yes or no ... and if the latter, why not?. Thromb Res. 2005 Nov 4; [Epub ahead of print] doi:10.1016/j.thromres.2005. 09.012.
    PubMedGoogle Scholar
  • 3 Tsaloumas MD, Kirwan J, Vinall H. et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 2000; 14: 821-7.
    CrossrefPubMedGoogle Scholar
  • 4 Lee KW, Lip GYH. Acute coronary syndromes: Virchow’s triad revisited. Blood Coagul Fibrinolysis 2003; 14: 605-25.
    CrossrefPubMedGoogle Scholar
  • 5 Prandoni P, Bilora F, Marchiori A. et al. An association between atherosclerosis and venous thrombosis. N Eng J Med 2003; 348: 1435-41.
    CrossrefPubMedGoogle Scholar
  • 6 Bova C, Marchiori A, Noto A. et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. Thromb Haemost 2006; 132-6.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 7 Blann AD, Lip GY. Venous thromboembolism. BMJ 2006; 332: 215-9.
    CrossrefPubMedGoogle Scholar
  • 8 Prandoni P, Bilora F, Marchiori A. et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 1435-41.
    CrossrefPubMedGoogle Scholar
  • 9 Maier W, Altwegg LA, Corti R. et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005; 111: 1355-61.
    CrossrefPubMedGoogle Scholar
  • 10 Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263-71.
    CrossrefPubMedGoogle Scholar
  • 11 Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-54.
    CrossrefPubMedGoogle Scholar
  • 12 Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2004; 02: 619-22.
    CrossrefPubMedGoogle Scholar
  • 13 van Aken BE, Reitsma PH, Rosendaal FR. Interleukin-8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002; 116: 173-7.
    CrossrefPubMedGoogle Scholar
  • 14 Lip PL, Blann AD, Jones AF. et al. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998; 12: 245-51.
    CrossrefPubMedGoogle Scholar
  • 15 Ray JG, Mamdani M, Tsuyuki RT. et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-10.
    CrossrefPubMedGoogle Scholar